Cryopreservation of Ovarian Tissue

Recruiting now · Not applicable

Conditions studied: Cancer, Risk of Premature Ovarian Failure, Fertility Preservation

In brief

The study hopes to contribute to the development of technologies of ovarian tissue freezing-thawing and in vitro maturation of immature eggs such that a person at risk for premature ovarian failure might be able to conceive a genetically related child.

Key facts

Study ID

NCT01558544

Run by

Weill Medical College of Cornell University

People needed

300

Starts

1997-04-01

Expected to finish

2029-10-31

Last updated by the study team

2025-12-10

Who can join

Age: any, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Females 0-45 years of age who are premenopausal
• Treatment plan that will likely result in premature menopause or premature ovarian failure
• This includes patients receiving:
• Cancer treatment with abdominal pelvic irradiation and/or high dose chemotherapy
• Surgery that requires removal of ovaries for medical condition or disease, e.g. Prophylactic oophorectomy in BRCA patients
• Patient is unable or unwilling to pursue fertility preservation by freezing oocytes or embryos.
• Previous treatment for cancer is acceptable if patient still has ovarian function
• Patient is medically stable enough to undergo surgery (cleared for anesthesia)

You may not qualify if…

• Patients not meeting the above criteria
• Patients who have not received medical clearance from their physicians to undergo surgery
• Patients already experiencing menopause.

Where it is running

• Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.